Mar 18 |
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
|
Mar 13 |
Here's Why We're Not Too Worried About Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation
|
Mar 3 |
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Q4 2023 Syndax Pharmaceuticals Inc Earnings Call
|
Feb 28 |
Syndax Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 28 |
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2023 Earnings Call Transcript
|
Feb 27 |
Syndax Pharmaceuticals files for a mixed securities shelf
|
Feb 27 |
FDA accepts Incyte application for graft-versus-host disease drug
|
Feb 27 |
Syndax Pharmaceuticals GAAP EPS of -$1.00 misses by $0.04
|
Feb 27 |
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
|